Ken Fisher’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.04M | Buy |
+44,558
| New | +$3.16M | ﹤0.01% | 517 |
|
|
2024
Q1 | – | Sell |
-95,778
| Closed | -$2.64M | – | 1037 |
|
|
2023
Q4 | $2.64M | Sell |
95,778
-6,359
| -6% | -$145K | ﹤0.01% | 558 |
|
|
2023
Q3 | $2.29M | Sell |
102,137
-51,165
| -33% | -$1.9M | ﹤0.01% | 609 |
|
|
2023
Q2 | $6.23M | Sell |
153,302
-3,818
| -2% | -$187K | ﹤0.01% | 517 |
|
|
2023
Q1 | $7.61M | Sell |
157,120
-43,757
| -22% | -$2M | ﹤0.01% | 489 |
|
|
2022
Q4 | $7.67M | Sell |
200,877
-3,511
| -2% | -$146K | 0.01% | 486 |
|
|
2022
Q3 | $10.3M | Sell |
204,388
-22,909
| -10% | -$1.12M | 0.01% | 397 |
|
|
2022
Q2 | $9.11M | Buy |
227,297
+12,323
| +6% | +$432K | 0.01% | 365 |
|
|
2022
Q1 | $8.02M | Buy |
214,974
+11,000
| +5% | +$424K | ﹤0.01% | 399 |
|
|
2021
Q4 | $8.12M | Buy |
203,974
+27,818
| +16% | +$1.06M | ﹤0.01% | 410 |
|
|
2021
Q3 | $6.55M | Buy |
176,156
+15,671
| +10% | +$644K | ﹤0.01% | 398 |
|
|
2021
Q2 | $6.78M | Buy |
160,485
+4,097
| +3% | +$176K | ﹤0.01% | 398 |
|
|
2021
Q1 | $7.41M | Buy |
156,388
+6,282
| +4% | +$373K | 0.01% | 392 |
|
|
2020
Q4 | $9.16M | Sell |
150,106
-14,142
| -9% | -$833K | 0.01% | 365 |
|
|
2020
Q3 | $7.68M | Sell |
164,248
-19,567
| -11% | -$963K | 0.01% | 356 |
|
|
2020
Q2 | $9.33M | Sell |
183,815
-6,671
| -4% | -$328K | 0.01% | 339 |
|
|
2020
Q1 | $8.5M | Sell |
190,486
-35,324
| -16% | -$1.78M | 0.01% | 316 |
|
|
2019
Q4 | $10.8M | Sell |
225,810
-41,813
| -16% | -$1.78M | 0.01% | 337 |
|
|
2019
Q3 | $9.05M | Sell |
267,623
-105
| -0% | -$4.57K | 0.01% | 373 |
|
|
2019
Q2 | $12M | Buy |
267,728
+135,289
| +102% | +$5.34M | 0.01% | 345 |
|
|
2019
Q1 | $4.99M | Hold |
132,439
| – | – | 0.01% | 415 |
|
|
2018
Q4 | $4.54M | Sell |
132,439
-1,357
| -1% | -$48.8K | 0.01% | 423 |
|
|
2018
Q3 | $6.29M | Sell |
133,796
-15,104
| -10% | -$625K | 0.01% | 396 |
|
|
2018
Q2 | $5.02M | Sell |
148,900
-8,935
| -6% | -$279K | 0.01% | 432 |
|
|
2018
Q1 | $4.27M | Sell |
157,835
-7,823
| -5% | -$198K | 0.01% | 446 |
|
|
2017
Q4 | $2.76M | Sell |
165,658
-7,387
| -4% | -$125K | ﹤0.01% | 494 |
|
|
2017
Q3 | $3.46M | Buy |
173,045
+83,403
| +93% | +$1.63M | ﹤0.01% | 440 |
|
|
2017
Q2 | $1.64M | Hold |
89,642
| – | – | ﹤0.01% | 497 |
|
|
2017
Q1 | $882K | Buy |
89,642
+1,800
| +2% | +$21.8K | ﹤0.01% | 515 |
|
|
2016
Q4 | $958K | Sell |
87,842
-1,800
| -2% | -$18.9K | ﹤0.01% | 512 |
|
|
2016
Q3 | $1.26M | Hold |
89,642
| – | – | ﹤0.01% | 503 |
|
|
2016
Q2 | $670K | Buy |
89,642
+3,942
| +5% | +$28.9K | ﹤0.01% | 538 |
|
|
2016
Q1 | $764K | Buy |
+85,700
| New | +$1.49M | ﹤0.01% | 535 |
|
Other funds holding PTCT
RI
VPM
VCM
AC
Ken Fisher's PTCT Position: Q1 2026 in Review
Ken Fisher opened a new position in PTC Therapeutics (PTCT) in Q1 2026: 44,558 shares worth $3.04M. The stake represents ﹤0.01% of the portfolio and ranks #517 among its holdings. This is a return to the name: Ken Fisher previously reported a position in PTCT as recently as Q4 2023.
Ken Fisher first reported a position in PTCT in Q1 2016 and has held it in 33 quarters since. The position peaked at $12M in Q2 2019. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.
- Ken Fisher held 44,558 shares of PTC Therapeutics worth $3.04M as of Q1 2026.
- PTC Therapeutics was a new Ken Fisher position in Q1 2026.
- PTC Therapeutics made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #517 holding.
- Ken Fisher first reported a position in PTC Therapeutics in Q1 2016 and has held it in 33 quarters since.
- Ken Fisher's PTC Therapeutics position peaked at $12M in Q2 2019.
- 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.